Movement Alert｜METIS TECHBIO-P Intraday Decline 5.01%, Biotechnology Sector Under Broad Pressure

Market Focus

Oct 12

On October 12, METIS TECHBIO-P fell 5.01% in regular trading, trading at 13.84 HKD/share, with turnover of 55.64 million HKD. The stock was pressured as the broader biotechnology sector faced a systemic pullback following a period of sharp gains in Hong Kong-listed biotech names, with AI-driven drug discovery concepts also broadly under pressure. Recent shifts in U.S. interest rate expectations have continued to weigh on high-duration, zero-revenue biotech companies.

From a fundamental standpoint, the company's interim results showed revenue of 154 million yuan, a year-on-year surge of 13,399%, while adjusted net loss narrowed 56.4% to 51 million yuan. Despite these improvements, short-term sector-wide risk-off sentiment dominated the price action.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketd.com/news/1180966225"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180966225\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180966225?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-12 13:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180966225","market":"hk","top_or_hot":-1,"title":"Movement Alert｜METIS TECHBIO-P Intraday Decline 5.01%, Biotechnology Sector Under Broad Pressure","media":"Market Focus","content":"<p><p>On October 12, METIS TECHBIO-P fell 5.01% in regular trading, trading at 13.84 HKD/share, with turnover of 55.64 million HKD. The stock was pressured as the broader biotechnology sector faced a systemic pullback following a period of sharp gains in Hong Kong-listed biotech names, with AI-driven drug discovery concepts also broadly under pressure. Recent shifts in U.S. interest rate expectations have continued to weigh on high-duration, zero-revenue biotech companies.</p><p>From a fundamental standpoint, the company's interim results showed revenue of 154 million yuan, a year-on-year surge of 13,399%, while adjusted net loss narrowed 56.4% to 51 million yuan. Despite these improvements, short-term sector-wide risk-off sentiment dominated the price action.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜METIS TECHBIO-P Intraday Decline 5.01%, Biotechnology Sector Under Broad Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜METIS TECHBIO-P Intraday Decline 5.01%, Biotechnology Sector Under Broad Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-12 13:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 12, METIS TECHBIO-P fell 5.01% in regular trading, trading at 13.84 HKD/share, with turnover of 55.64 million HKD. The stock was pressured as the broader biotechnology sector faced a systemic pullback following a period of sharp gains in Hong Kong-listed biotech names, with AI-driven drug discovery concepts also broadly under pressure. Recent shifts in U.S. interest rate expectations have continued to weigh on high-duration, zero-revenue biotech companies.</p><p>From a fundamental standpoint, the company's interim results showed revenue of 154 million yuan, a year-on-year surge of 13,399%, while adjusted net loss narrowed 56.4% to 51 million yuan. Despite these improvements, short-term sector-wide risk-off sentiment dominated the price action.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1180966225","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180966225","pubTimestamp":1791783141,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 12, METIS TECHBIO-P fell 5.01% in regular trading, trading at 13.84 HKD/share, with turnover of 55.64 million HKD. The stock was pressured as the broader biotechnology sector faced a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"走势警报|METIS TECHBIO-P盘中下跌5.01%，生物技术板块普遍承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"On October 12, METIS TECHBIO-P fell 5.01% in regular trading, trading at 13.84 HKD/share, with turnover of 55.64 million HKD. The stock was pressured as the broader biotechnology sector faced a systemic pullback following a period of sharp gains in Hong Kong-listed biotech names, with AI-driven drug discovery concepts also broadly under pressure. Recent shifts in U.S. interest rate expectations have continued to weigh on high-duration, zero-revenue biotech companies.From a fundamental standpoint, the company's interim results showed revenue of 154 million yuan, a year-on-year surge of 13,399%, while adjusted net loss narrowed 56.4% to 51 million yuan. Despite these improvements, short-term sector-wide risk-off sentiment dominated the price action.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}